ArticleJournal of cheminformatics2018
An automated framework for QSAR model building.
Article in Journal of cheminformatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Democratizing Artificial Intelligence in Toxicology: Real-World Applications and Automated Computational Workflows.Chemical research in toxicology · 2026Review
- Natural Products in Epilepsy Treatment: From Traditional Medicine Towards Computational Drug Discovery.Current issues in molecular biology · 2026Review
- SPARFlow: a KNIME workflow for integrated structure-activity or structure-property relationship analysis.Journal of cheminformatics · 2026Article
- Optimizing Multi-Task Learning with Evolutionary Relatedness Metrics for Enhanced QSAR-Based Natural Product Activity Prediction.ACS omega · 2025Article
- QSPR analysis of physico-chemical and pharmacological properties of medications for Parkinson's treatment utilizing neighborhood degree-based topological descriptors.Scientific reports · 2025Article
- Discovery of SARS-CoV-2 Nsp14-Methyltransferase (MTase) Inhibitors by Harnessing Scaffold-Centric Exploration of the Ultra Large Chemical Space.ACS pharmacology & translational science · 2025Article
- Applications of Machine Learning Approaches for the Discovery of SARS-CoV-2 PLpro Inhibitors.Journal of chemical information and modeling · 2025Article
- Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors.Computational and structural biotechnology journal · 2024Review
- SerotoninAI: Serotonergic System Focused, Artificial Intelligence-Based Application for Drug Discovery.Journal of chemical information and modeling · 2024Article
- Inferring molecular inhibition potency with AlphaFold predicted structures.Scientific reports · 2024Article
- Special Issue "Computer-Aided Drug Discovery and Treatment".International journal of molecular sciences · 2024Article
- Application of QSAR Approach to Assess the Effects of Organic Pollutants on Bacterial Virulence Factors.Microorganisms · 2023Article
- In silico analysis of noscapine compounds as anti-tumor agents targeting the tubulin receptor.Journal of Taibah University Medical Sciences · 2023Article
- A breast cancer-specific combinational QSAR model development using machine learning and deep learning approaches.Frontiers in bioinformatics · 2023Article
- Article
- Article
- DockStream: a docking wrapper to enhance de novo molecular design.Journal of cheminformatics · 2021Article
- A hybrid modeling approach for assessing mechanistic models of small molecule partitioning in vivo using a machine learning-integrated modeling platform.Scientific reports · 2021Article
- From genomes to molecular dynamics - A bottom up approach in extrication of SARS CoV-2 main protease inhibitors.Computational toxicology (Amsterdam, Netherlands) · 2021Article
- Flame: an open source framework for model development, hosting, and usage in production environments.Journal of cheminformatics · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundIn-silico quantitative structure-activity relationship (QSAR) models based tools are widely used to screen huge databases of compounds in order to determine the biological properties of chemical molecules based on their chemical structure. With the passage of time, the exponentially growing amount of synthesized and known chemicals data demands computationally efficient automated QSAR modeling tools, available to researchers that may lack extensive knowledge of machine learning modeling. Thus, a fully automated and advanced modeling platform can be an important addition to the QSAR community.
resultsIn the presented workflow the process from data preparation to model building and validation has been completely automated. The most critical modeling tasks (data curation, data set characteristics evaluation, variable selection and validation) that largely influence the performance of QSAR models were focused. It is also included the ability to quickly evaluate the feasibility of a given data set to be modeled. The developed framework is tested on data sets of thirty different problems. The best-optimized feature selection methodology in the developed workflow is able to remove 62-99% of all redundant data. On average, about 19% of the prediction error was reduced by using feature selection producing an increase of 49% in the percentage of variance explained (PVE) compared to models without feature selection. Selecting only the models with a modelability score above 0.6, average PVE scores were 0.71. A strong correlation was verified between the modelability scores and the PVE of the models produced with variable selection.
conclusionsWe developed an extendable and highly customizable fully automated QSAR modeling framework. This designed workflow does not require any advanced parameterization nor depends on users decisions or expertise in machine learning/programming. With just a given target or problem, the workflow follows an unbiased standard protocol to develop reliable QSAR models by directly accessing online manually curated databases or by using private data sets. The other distinctive features of the workflow include prior estimation of data modelability to avoid time-consuming modeling trials for non modelable data sets, an efficient variable selection procedure and the facility of output availability at each modeling task for the diverse application and reproduction of historical predictions. The results reached on a selection of thirty QSAR problems suggest that the approach is capable of building reliable models even for challenging problems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.